Haiqiong Zhang

State Key Laboratory Of Complex, Beijing Key Laboratory Of Molecular Targeted Diagnosis And Therapy In Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy Of Medical Science And Peking Union Medical College
Beijing, 100730, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Beyond tumor tracing: physiological uptake of sympathetic ganglia on somatostatin receptor PET/CT - prevalence, patterns, and biological rationale.

Beyond tumor tracing: physiological uptake of sympathetic ganglia on somatostatin receptor PET/CT - prevalence, patterns, and biological rationale.

Journal: European journal of nuclear medicine and molecular imaging
Published: March 19, 2026

Quantification of image quality and partial volume effect along the axial field-of-view of uMI Panorama GS PET/CT system for multiple radionuclides.

Quantification of image quality and partial volume effect along the axial field-of-view of uMI Panorama GS PET/CT system for multiple radionuclides.

Journal: EJNMMI physics
Published: February 06, 2026

A Novel 68Ga-Labeled Integrin α4β7-Targeted Radiopharmaceutical for PET/CT Imaging of DSS-Induced Murine Colitis.

A Novel 68Ga-Labeled Integrin α4β7-Targeted Radiopharmaceutical for PET/CT Imaging of DSS-Induced Murine Colitis.

Journal: Pharmaceutics
Published: October 31, 2025

Standardized quantification of [18F]Florbetazine amyloid PET with the Centiloid scale.

Standardized quantification of [18F]Florbetazine amyloid PET with the Centiloid scale.

Journal: NeuroImage
Published: October 12, 2025

Assessment of the diagnostic efficacy and clinical significance of [18F]AlF-NOTA-LM3 PET/CT in patients with well-differentiated neuroendocrine tumors.

Assessment of the diagnostic efficacy and clinical significance of [18F]AlF-NOTA-LM3 PET/CT in patients with well-differentiated neuroendocrine tumors.

Journal: European journal of nuclear medicine and molecular imaging
Published: March 27, 2025

The diagnostic performance of [18F]Florbetazine in Alzheimer's disease: a head-to-head comparison to [11C]PiB and [18F]Florbetapir.

The diagnostic performance of [18F]Florbetazine in Alzheimer's disease: a head-to-head comparison to [11C]PiB and [18F]Florbetapir.

Journal: European journal of nuclear medicine and molecular imaging
Published: January 22, 2025

Feasibility of simplified Patlak parametric imaging with scaled population-based input function on pancreatic cancer.

Feasibility of simplified Patlak parametric imaging with scaled population-based input function on pancreatic cancer.

Journal: EJNMMI physics
Published: September 17, 2024

Ultra-fast [18F]florbetapir PET imaging using the uMI Panorama PET/CT system.

Ultra-fast [18F]florbetapir PET imaging using the uMI Panorama PET/CT system.

Journal: EJNMMI physics
Published: August 04, 2024

Performance Characteristics of a New Generation 148-cm Axial Field-of-View uMI Panorama GS PET/CT System with Extended NEMA NU 2-2018 and EARL Standards.

Performance Characteristics of a New Generation 148-cm Axial Field-of-View uMI Panorama GS PET/CT System with Extended NEMA NU 2-2018 and EARL Standards.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 16, 2024

Feasibility of a deep-inspiration breath-hold [18F]AlF-NOTA-LM3 PET/CT imaging on upper-abdominal lesions in NET patients: in comparison with respiratory-gated PET/CT.

Feasibility of a deep-inspiration breath-hold [18F]AlF-NOTA-LM3 PET/CT imaging on upper-abdominal lesions in NET patients: in comparison with respiratory-gated PET/CT.

Journal: EJNMMI physics
Published: April 14, 2024

Evaluation of a novel PET tracer [18F]-Florbetazine for Alzheimer's disease diagnosis and β-amyloid deposition quantification.

Evaluation of a novel PET tracer [18F]-Florbetazine for Alzheimer's disease diagnosis and β-amyloid deposition quantification.

Journal: NeuroImage
Published: March 12, 2024

Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NOTA-LM3 and head-to-head comparison with [68Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial.

Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NOTA-LM3 and head-to-head comparison with [68Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial.

Journal: European journal of nuclear medicine and molecular imaging
Published: March 06, 2024
Showing 1-12 of 15

Last Updated: 09/26/2026